Percutaneous Tendo Achillis Lengthening to Promote Healing of Diabetic Plantar Foot Ulceration

2005 ◽  
Vol 95 (3) ◽  
pp. 281-284 ◽  
Author(s):  
Amanda Willrich ◽  
Arush K. Angirasa ◽  
Ronald A. Sage
Keyword(s):  
Diabetes Mellitus ◽  
Range Of Motion ◽  
Plantar Pressure ◽  
Case Reports ◽  
Shear Forces ◽  
Foot Ulceration ◽  
Crucial Component ◽  
Patients With Diabetes ◽  
Tendo Achillis ◽  
Viable Treatment

The etiology of ulcerations related to increased plantar pressure in patients with diabetes mellitus is complex but frequently includes a component of gastrocnemius soleus equinus. One viable treatment option is percutaneous tendo Achillis lengthening as a means of increasing dorsiflexory range of motion and decreasing forefoot shear forces. This article presents three case reports illustrating the importance of reducing plantar pressure as a crucial component of treatment of diabetic forefoot ulcerations. (J Am Podiatr Med Assoc 95(3): 281–284, 2005)

scholarly journals The effect of shoe sole stiffness on plantar pressure and patient satisfaction in patients with diabetes at high risk of foot ulceration

2017 ◽  
Vol 9 (sup1) ◽  
pp. S126-S127
Author(s):  
Jennefer Zwaferink ◽  
Heleen Berendsen ◽  
Wim Custers ◽  
Irma Paardekooper ◽  
Sicco Bus
Keyword(s):  
Patient Satisfaction ◽  
High Risk ◽  
Plantar Pressure ◽  
Foot Ulceration ◽  
Patients With Diabetes

A Review of Causes of Foot Ulceration in Patients with Diabetes Mellitus

1991 ◽  
Vol 4 (1) ◽  
pp. 13???22 ◽  
Author(s):  
James A. Birke ◽  
Andrew Novick ◽  
Elizabeth S. Hawkins ◽  
Charles Patout
Keyword(s):  
Diabetes Mellitus ◽  
Foot Ulceration ◽  
Patients With Diabetes

Effectiveness of various materials in reducing plantar shear forces. A pilot study

2000 ◽  
Vol 90 (7) ◽  
pp. 346-353 ◽  
Author(s):  
M Curryer ◽  
ED Lemaire
Keyword(s):  
Diabetes Mellitus ◽  
Pilot Study ◽  
Diabetic Foot ◽  
Shear Force ◽  
Foot Ulcers ◽  
Shear Forces ◽  
Patients With Diabetes ◽  
Force Data ◽  
Precipitating Factor ◽  
Better Than

Vertical plantar forces are known to be a major precipitating factor in the development of foot pathology. It is also postulated that shear forces are important in the pathogenesis of foot ulcers in patients with diabetes mellitus. Various materials are used in insoles designed to reduce forces on the foot. While many foam materials have been tested for their ability to dissipate vertical forces, few studies have tested the effect of these materials on shear forces. This study assessed the effectiveness of five different materials in reducing plantar shear forces and compared two new gel materials with three of the more conventional foam materials. Four subjects were tested while walking over a force platform with one of the five materials taped to the surface. Peak force, impulse, and resultant shear force data were analyzed. The gel materials were significantly better than the foam materials at reducing shear forces. Thus the use of gel materials in insoles may be indicated for the reduction of plantar shear forces on the diabetic foot.

Foot Function in Diabetic Patients after Partial Amputation

1996 ◽  
Vol 17 (1) ◽  
pp. 43-48 ◽  
Author(s):  
Juan Carlos Garbalosa ◽  
Peter R. Cavanagh ◽  
Ge Wu ◽  
Jan S. Ulbrecht ◽  
Mary B. Becker ◽  
...  
Keyword(s):  
Range Of Motion ◽  
Plantar Pressure ◽  
Three Dimensional ◽  
Diabetic Patients ◽  
Plantar Pressures ◽  
Plantar Pressure Distribution ◽  
Patients With Diabetes ◽  
Peak Plantar Pressure ◽  
Partial Amputation ◽  
Foot Function

The function of partially amputated feet in 10 patients with diabetes mellitus was studied. First-step bilateral barefoot plantar pressure distribution and three-dimensional kinematic data were collected using a Novel EMED platform and three video cameras. Analysis of the plantar pressure data revealed a significantly greater mean peak plantar pressure in the feet with transmetatarsal amputation (TMA) than in the intact feet of the same patients. The heels of the amputated feet had significantly lower mean peak plantar pressures than all the forefoot regions. A significantly greater maximum dynamic dorsiflexion range of motion was seen in the intact compared with the TMA feet. However, no difference was noted in the static dorsiflexion range of motion between the two feet and there was, therefore, a trend for the TMA feet to use less of the available range of motion. Given the altered kinematics and elevated plantar pressures noted in this study, careful postsurgical footwear management of feet with TMA would appear to be essential if ulceration is to be prevented.

Clinical and Dynamic Range-of-Motion Techniques in Subjects With and Without Diabetes Mellitus

2002 ◽  
Vol 92 (3) ◽  
pp. 136-142 ◽  
Author(s):  
Paul Tinley ◽  
Michael Taranto
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Range Of Motion ◽  
Dynamic Range ◽  
Control Group ◽  
Limited Joint Mobility ◽  
Study Results ◽  
Patients With Diabetes ◽  
Female Subjects

Thirty subjects with type 1 diabetes, 30 subjects with type 2 diabetes, and 30 age- and sex-matched controls were evaluated through clinical goniometry and two-dimensional motion analysis systems to determine the dynamic and static range of motion of the knee, ankle, and hallux joints. The purpose of this study was to determine if the knee and ankle joints of patients with diabetes mellitus are affected by limited joint mobility syndrome. The study results support previous medical literature showing significant reduction of range of motion of the hallux in subjects with type 1 diabetes. Significant differences were found between the range of motion of male and female subjects in all lower-limb joints for both subject groups with diabetes compared to the control group, and male subjects in all groups recorded less range of motion than female subjects. (J Am Podiatr Med Assoc 92(3): 136-142, 2002)

scholarly journals Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus

Nutrients ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 873 ◽  
Author(s):  
Martin M. Grajower ◽  
Benjamin D. Horne
Keyword(s):  
Diabetes Mellitus ◽  
Animal Studies ◽  
Case Reports ◽  
Glucose Monitoring ◽  
The United States ◽  
Intermittent Fasting ◽  
Diabetes Diagnosis ◽  
Fasting Period ◽  
Patients With Diabetes ◽  
The Many

Intermittent fasting is increasing in popularity as a means of losing weight and controlling chronic illness. Patients with diabetes mellitus, both types 1 and 2, comprise about 10% of the population in the United States and would likely be attracted to follow one of the many methods of intermittent fasting. Studies on the safety and benefits of intermittent fasting with diabetes are very limited though, and health recommendations unfortunately today arise primarily from weight loss gurus and animal studies. Medical guidelines on how to manage therapeutic intermittent fasting in patients with diabetes are non-existent. The evidence to build such a clinical guideline for people with a diabetes diagnosis is almost non-existent, with just one randomized trial and several case reports. This article provides an overview of the available knowledge and a review of the very limited pertinent literature on the effects of intermittent fasting among people with diabetes. It also evaluates the known safety and efficacy issues surrounding treatments for diabetes in the fasting state. Based on those limited data and a knowledge of best practices, this paper proposes expert-based guidelines on how to manage a patient with either type 1 or 2 diabetes who is interested in intermittent fasting. The safety of each relevant pharmaceutical treatment during a fasting period is considered. When done under the supervision of the patient’s healthcare provider, and with appropriate personal glucose monitoring, intermittent fasting can be safely undertaken in patients with diabetes.

Sign in / Sign up

Export Citation Format

Share Document